SCHEMBL7420196

SCHEMBL7420196

CC(C)(CC(N)=O)CC(=O)N(Cc1ccccc1)C1(C#N)CCNC1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CTSS P25774 5/20 0.36
CTSB P07858 4/20 0.36
CTSL P07711 2/20 0.36
CTSK P43235 3/20 0.35
CYP2D6 P10635 5/20 0.33
SLC6A2 P23975 4/20 0.33
SLC6A4 P31645 4/20 0.33
SLC6A3 Q01959 4/20 0.33
SNCA P37840 2/20 0.33
OPRM1 P35372 2/20 0.32
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
NPC1 O15118 1/20 0.31
HTT P42858 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
OPRD1 P41143 1/20 0.31
KCNH2 Q12809 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7419245 0.83 SIGMAR1 (0.41) CTSSCTSBCTSLCTSKNPC1
SCHEMBL7021621 0.82 RXFP1 (0.34) CTSSCTSBCTSLCTSKCYP2D6
SCHEMBL7420191 0.78 SNCA (0.34) CTSSCTSBCTSLCTSKCYP2D6
SCHEMBL7420985 0.77 ALDH1A1 (0.43) MEN1KMT2A
SCHEMBL7021618 0.74 SNCA (0.34) CTSSCTSLCTSKCYP2D6SLC6A2
SCHEMBL7415546 0.73 PSEN1 (0.34) CTSSCTSKCYP2D6
SCHEMBL7533079 0.72
SCHEMBL7416904 0.72 SNCA (0.35) CTSSCTSBCTSLCTSKCYP2D6
SCHEMBL6371524 0.72 L3MBTL1 (0.40) CTSSCTSKMEN1KMT2AHTT
SCHEMBL6371523 0.72 SNCA (0.33) CTSSCTSKSLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218372-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES Boehringer Ingelheim Pharmaceuticals, Inc. (US) 2002-07-03 EP disclosed
WO-2001019816-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2001-03-22 WO disclosed